Horizon Therapeutics Plc (HZNP)

27.50
NASDAQ : Health Technology
Prev Close 27.00
Day Low/High 26.94 / 27.62
52 Wk Low/High 16.56 / 29.44
Avg Volume 1.98M
Exchange NASDAQ
Shares Outstanding 186.45M
Market Cap 5.03B
EPS -0.50
P/E Ratio 69.23
Div & Yield N.A. (N.A)

Latest News

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

These names are showing bullish and bearish technical patterns over the past week.

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Volatility sank to its lowest level since 1993 to begin the new week as indexes held close to their flatlines.

Bears Are Losing Their Grip on Horizon Pharma

Bears Are Losing Their Grip on Horizon Pharma

The stock is slowly building a bullish setup.

Horizon Pharma Tanks on Failed Late-Stage Study

Horizon Pharma Tanks on Failed Late-Stage Study

Horizon's nueromuscular disorder treatment trials failed.

How Do the Charts Look for Jim Cramer's Weekly Shopping List?

How Do the Charts Look for Jim Cramer's Weekly Shopping List?

No matter who wins the election, there are ways to make money.

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar

Relief flooded Wall Street after a number of Fed speakers took a dovish turn following increasingly hawkish rhetoric.

Tweets on the Street: Pimco's Eurozone Concerns, Shkreli on Horizon Pharma

Social media chatter also included takes by Michael Bloomberg and Warren Buffett on small-business success.

A Move Lower Is on the Horizon (Pharma)

Don't be surprised if HZNP trends lower to next chart support around $10.

Horizon Pharma Needs a Health Check

HZNP could work lower to $10 in the weeks and months ahead.

Cramer: Collateral Damage Is Giving These Stocks a Bad Name

But for the brave, they could offer a solid bottom-fishing opportunity.

Jim Cramer Recommends Ford Over General Motors Among Autos

Jim Cramer Recommends Ford Over General Motors Among Autos

Automakers are reporting sales results today, and Ford is Jim Cramer’s top pick in the auto sector.

Silly Season Continues for Biotech

Silly Season Continues for Biotech

Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

Retrophin (RTRX), the biotech company that used to be run by indicted hedge fund manager Martin Shkreki, provides an interesting investment opportunity.

Jim Cramer Says Don't Rush in to Buy Stocks in Monday Selloff

Jim Cramer Says Don't Rush in to Buy Stocks in Monday Selloff

Jim Cramer says don’t rush into the stock market in Monday's trading session looking for bargains in the midst of a selloff.

Bah Humbug Macy's, Jim Cramer Says the Holiday Season Belongs to Amazon

Bah Humbug Macy's, Jim Cramer Says the Holiday Season Belongs to Amazon

Jim Cramer, portfolio manager at TheStreet’s Action Alerts PLUS and host of CNBC’s ‘Mad Money’ said Amazon (AMZN) stock is going higher because the company’s business model is so good.

Why Biotech Has Bottomed

Investors should ignore the temporary issues that have knocked the sector down.

Why Biotech Has Bottomed

Why Biotech Has Bottomed

Investors should ignore the temporary issues that have knocked the sector down.

Targets of Market Hatred Can Change Daily

It used to be industrials, now it's health care.

Jim Cramer Says Tech Giants Microsoft, IBM Should Make Acquisitions

Jim Cramer Says Tech Giants Microsoft, IBM Should Make Acquisitions

Jim Cramer says Microsoft (MSFT) will report a decent quarter, thanks to Windows 10, but he wishes the company would make an acquisition.

A Small Pharma Stock With Big Potential

A Small Pharma Stock With Big Potential

Pernix looks poised for a strong 2016.

How to Build a Good Foundation in Biotechs

How to Build a Good Foundation in Biotechs

A so-called "pyramid strategy" can help you enter the depressed sector.

Hedge Funds Doing Battle Over Ailing Stocks

There's blood in the water.

The Biotechs Are Being Taken Out and Shot

All you can do is wait until they bottom out.

Horizon and ANI Appeal in Pharma Selloff

Horizon and ANI Appeal in Pharma Selloff

Some smaller biotechs offer good value at current levels.

Market Wrap: Stocks Sink Across the Board

Materials and technology names led the way down on the session.